Setrusumab

Drug identity checked against registry records

Also recorded as BPS804; UX143

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis ImperfectaNCT05312697RAREPhase 2Terminated2022-07-07Actual
Setrusumab vs Placebo for Osteogenesis ImperfectaNCT05125809RAREPhase 2, Phase 3Active not recruiting2025-10-20Actual
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaNCT05768854RAREPhase 3Active not recruiting2025-10-23Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.